Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Bäck Jennie) > Contact activation ...

Bäck, JennieUppsala universitet,Institutionen för immunologi, genetik och patologi,Bo NiIsson,Uppsala University (författare)

Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus

Artikel/kapitelEngelska2013

Förlag, utgivningsår, omfång ...

Springer Science and Business Media LLC,2013
printrdacarrier

Nummerbeteckningar

LIBRIS-ID:oai:DiVA.org:lnu-32678
https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-32678URI
https://doi.org/10.1186/ar4399DOI
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-220567URI
https://lup.lub.lu.se/record/c157d69f-2124-48dc-b514-3b14105f111eURI

Kompletterande språkuppgifter

Språk:engelska
Sammanfattning på:engelska

Ingår i deldatabas

SwePubSwePub

Klassifikation

Ämneskategori:ref swepub-contenttype
Ämneskategori:art swepub-publicationtype

Anmärkningar

Introduction: Patients with systemic lupus erythematosus (SLE) have persistent platelet activation and an increased risk of thrombotic events, which cannot be accounted for by traditional cardiovascular risk factors. Factor (F)XII has a potentially important role in thrombus formation and is triggered by activated platelets. We therefore asked whether the contact system is involved in inflammation and vascular disease (VD) in SLE. Methods: Fibrin clots were incubated with purified FXII or whole blood, and the activation and regulation of FXII were studied. Plasma from SLE patients with (n = 31) or without (n = 38) previous VD and from matched healthy controls (n = 68) were analyzed for the presence of complexes formed between contact system enzymes and antithrombin (AT) or C1 inhibitor (C1INH) and evaluated with regard to clinical data and laboratory parameters. Results: Fibrin clots elicited FXII activation and acted as co-factors for AT. In clotting plasma, the levels of FXIIa-AT increased, and FXIIa-C1INH decreased. A similar reciprocal relationship existed in SLE patients. FXIIa-AT was elevated in the SLE patients with a history of VD, while the corresponding levels of factor FXIIa-C1INH were significantly decreased. FXIIa-AT correlated strongly with platelet parameters. The odds ratio for VD among the SLE patients was 8.9 if they had low levels of FXIIa-C1INH, 6.1 for those with high levels of FXIIa-AT, and increased to 23.4 for those with both decreased levels of FXIIa-C1INH and increased levels of FXIIa-AT. Conclusions: Activation of FXII is elicited by fibrin during thrombotic reactions in vitro and in vivo, and fibrin acts as a heparin-like co-factor and regulates AT. Patients with SLE had altered levels of FXIIa-serpin complexes, supporting that the contact system is involved in this disease. FXIIa-serpin complexes are strongly associated with previous VD in SLE patients, suggesting that these complexes are potential biomarkers for monitoring and assessing the risk of thrombotic events in SLE.

Ämnesord och genrebeteckningar

NATURVETENSKAP Biologi Immunologi hsv//swe
NATURAL SCIENCES Biological Sciences Immunology hsv//eng
MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Reumatologi och inflammation hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Rheumatology and Autoimmunity hsv//eng
Biomedicinsk vetenskap
Biomedical Sciences

Biuppslag (personer, institutioner, konferenser, titlar ...)

Lood, ChristianLund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital(Swepub:lu)med-ctl (författare)
Bengtsson, Anders A.Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Lund SLE Research Group,Forskargrupper vid Lunds universitet,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University Research Groups,Skåne University Hospital(Swepub:lu)reum-abe (författare)
Nilsson Ekdahl, KristinaLinnaeus University,Uppsala universitet,Linnéuniversitetet,Institutionen för kemi och biomedicin (KOB),Uppsala University,Linnaeus Ctr Biomat Chem, BMC,Institutionen för immunologi, genetik och patologi,Bo Nilsson(Swepub:uu)krisnil (författare)
Nilsson, BoUppsala universitet,Institutionen för immunologi, genetik och patologi,Bo Nilsson,Uppsala University(Swepub:uu)bonils (författare)
Uppsala universitetInstitutionen för immunologi, genetik och patologi (creator_code:org_t)

Sammanhörande titlar

Ingår i:Arthritis Research & Therapy: Springer Science and Business Media LLC15:61478-63621478-6354

Internetlänk

Hitta via bibliotek

Arthritis Research & Therapy (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Bäck, Jennie; Lood, Christian; Bengtsson, Ander ...; Nilsson Ekdahl, ...; Nilsson, Bo

Om ämnet

NATURVETENSKAP: NATURVETENSKAP; och Biologi; och Immunologi

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Reumatologi och ...

Artiklar i publikationen: Arthritis Resear ...

Av lärosätet: Linnéuniversitetet; Uppsala universitet; Lunds universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se